FGFR3 was a hit in our MERLIN-network based prioritization siRNA study and acts as a modulator of the JAK-STAT pathway in growth disorders such as achondroplasia (OMIM). The gene discussed is FGFR3; the disease is hereditary endocrine growth disease.